LANREOTIDE ACETATE

Generic: LANREOTIDE ACETATE

Cipla USA Inc.Manufacturer
SUBCUTANEOUSRoute
LANREOTIDE ACETATEActive Substance
2024-05-21Original Approval

LANREOTIDE ACETATE is FDA application ANDA217193, sponsored by INVAGEN PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DEATH
1,038 reports
2
OFF LABEL USE
943 reports
3
DIARRHOEA
596 reports
4
FATIGUE
454 reports
5
ABDOMINAL PAIN
347 reports
6
NAUSEA
328 reports
7
MALIGNANT NEOPLASM PROGRESSION
327 reports
8
WEIGHT DECREASED
281 reports
9
MALAISE
270 reports
10
ASTHENIA
269 reports